Related Experiment Videos
Structure-activity relationships of cyclic beta-casomorphin-5 analogues
Peptides
|November 1, 1991
Summary
Cyclic beta-casomorphin-5 analogues with D-amino acids show high opioid receptor affinity and potency. Configurational changes at specific positions modulated receptor interactions, offering insights into opioid peptide design.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Peptide Science
Background:
- Beta-casomorphin-5 is a peptide derived from beta-casein with opioid activity.
- Opioid peptides interact with mu and delta receptors, influencing various physiological processes.
Purpose of the Study:
- To synthesize and evaluate cyclic analogues of beta-casomorphin-5.
- To investigate the structure-activity relationships of these cyclic analogues at opioid receptors.
Main Methods:
- Synthesis of cyclic peptides by substituting Pro2 with diamino acids and cyclization.
- Assessment of opioid receptor binding affinity (mu and delta receptors).
- Evaluation of biological activity using guinea pig ileum and mouse vas deferens assays.
Main Results:
- Cyclic analogues with D-configuration at position 2 exhibited high opioid receptor affinity and potency.
- Compounds showed a preference for mu receptors over delta receptors.
- Configurational inversion at position 4 enhanced affinity for both mu and delta receptors.
- N-methylation of Phe3 reduced potency.
Conclusions:
- Cyclic beta-casomorphin-5 analogues can be designed to target opioid receptors effectively.
- Stereochemistry at positions 2 and 4 significantly influences receptor binding and activity.
- These findings provide a basis for developing novel opioid-modulating agents.